For the small cohort of AOM patients who do switch, tirzepatide is the most common agent, and nearly half opt to pay cash for Zepbound, often through LillyDirects direct-to-consumer platform
Proper storage is a foundational part of GLP-1 treatment success
For musculoskeletal injuries that aren't responding to conventional treatment, the combination of PRP injections and orthobiologics has substantially more human clinical evidence behind it than BPC-157
Decreased Strength and Mobility : Muscle atrophy can lead to weakness, reduced functional ability, and a higher risk of falls, especially in older adults
September 2025: In an unusual move for a defendant, Eli Lilly and other defendants listed in the GLP-1 drug group lawsuit have asked for another group lawsuit against the drugs to be formed
It activates the skin care repair process